Latest / The Vox Markets Podcast
2031: Q&A with Oncimmune CEO, Martin Gouldstone
Watch on YouTube
After this morning's trading update, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services to the Biopharma industry – takes me through the company's current demand picture, pipeline and August FY25 guidance.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.